AKUS - Akouos, Inc.

Gainer Signal for 05-20-2022
Loading Chart AKUS

Stock Signal Information


Gainer Stock Signal: AKUS
Report Date: 05-20-2022
Company: Akouos, Inc. (AKUS)
Sector: Healthcare
Industry: Biotechnology

AKUS Technical Analysis

Company Contact

Akouos, Inc. (AKUS)
645 Summer Street
Boston, MA 02210
Phone: 857 410 1818
Website: https://www.akouos.com
CEO: Dr. Emmanuel Simons M.B.A., Ph.D.

AKUS, Akouos, Inc.

AKUS Akouos, Inc. Logo Image

NASDAQ, Nasdaq Global Select

Company Profile

Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. The company is also developing AK-CLRN1 for the auditory manifestations of Usher syndrome 3A, or USH3A; and AK-antiVEGF for vestibular schwannoma. In addition, its precision genetic medicine platform addresses hearing loss related to genes needed for supporting cell function. Akouos, Inc. was incorporated in 2016 and is based in Boston, Massachusetts.

Top Stock Signals

best stock trading signals, free trading signals, best stock signal alert software

About Top Stock Signals

Good stock signals have been found on this server. That is all we know.

Phone: +1 (407) 559-7228
Email: [email protected]

About Us | Newsletter | Members

Most Active
Top Gainers
Top Losers